177 related articles for article (PubMed ID: 38523222)
21. Involvement of mental health professionals in the treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND): results of a multinational European electronic survey.
Waltereit R; Beaure d'Augères G; Jancic J; Kingswood JC; Koleva M; Marques R; Villanueva V; Auvin S
Orphanet J Rare Dis; 2021 May; 16(1):216. PubMed ID: 33980296
[TBL] [Abstract][Full Text] [Related]
22. Tuberous sclerosis complex-associated neuropsychiatric disorder (TAND) in a low-resource setting - From seizure to psychosis: A case report.
Pokharel S; Jyotsana P; Maharjan RS; Singh R; Pandit K
Ann Med Surg (Lond); 2020 Dec; 60():734-736. PubMed ID: 33425343
[TBL] [Abstract][Full Text] [Related]
23. Development and Feasibility of the Self-Report Quantified Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders Checklist (TAND-SQ).
Heunis TM; Chambers N; Vanclooster S; Bissell S; Byars AW; Capal JK; Cukier S; Davis PE; de Vries MC; De Waele L; Flinn J; Gardner-Lubbe S; Gipson T; Kingswood JC; Krueger DA; Kumm AJ; Sahin M; Schoeters E; Smith C; Srivastava S; Takei M; van Eeghen AM; Waltereit R; Jansen AC; de Vries PJ
Pediatr Neurol; 2023 Oct; 147():101-123. PubMed ID: 37598571
[TBL] [Abstract][Full Text] [Related]
24. International consensus recommendations for the identification and treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND).
de Vries PJ; Heunis TM; Vanclooster S; Chambers N; Bissell S; Byars AW; Flinn J; Gipson TT; van Eeghen AM; Waltereit R; Capal JK; Cukier S; Davis PE; Smith C; Kingswood JC; Schoeters E; Srivastava S; Takei M; Gardner-Lubbe S; Kumm AJ; Krueger DA; Sahin M; De Waele L; Jansen AC
J Neurodev Disord; 2023 Sep; 15(1):32. PubMed ID: 37710171
[TBL] [Abstract][Full Text] [Related]
25. The role of glia in epilepsy, intellectual disability, and other neurodevelopmental disorders in tuberous sclerosis complex.
Wong M
J Neurodev Disord; 2019 Dec; 11(1):30. PubMed ID: 31838997
[TBL] [Abstract][Full Text] [Related]
26. Sirolimus relieves seizures and neuropsychiatric symptoms via changes of microglial polarity in tuberous sclerosis complex model mice.
Koike-Kumagai M; Fujimoto M; Wataya-Kaneda M
Neuropharmacology; 2022 Nov; 218():109203. PubMed ID: 35931213
[TBL] [Abstract][Full Text] [Related]
27. Multivariate data analysis identifies natural clusters of Tuberous Sclerosis Complex Associated Neuropsychiatric Disorders (TAND).
de Vries PJ; Leclezio L; Gardner-Lubbe S; Krueger D; Sahin M; Sparagana S; De Waele L; Jansen A
Orphanet J Rare Dis; 2021 Oct; 16(1):447. PubMed ID: 34689816
[TBL] [Abstract][Full Text] [Related]
28. Tuberous sclerosis complex-associated neuropsychiatric disorders.
Marcinkowska AB; Tarasewicz A; Jóźwiak S; Dębska-Ślizień A; Szurowska E
Psychiatr Pol; 2022 May; ():1-20. PubMed ID: 36370437
[TBL] [Abstract][Full Text] [Related]
29. Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders (TAND): New Findings on Age, Sex, and Genotype in Relation to Intellectual Phenotype.
de Vries PJ; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; Dahlin M; D'Amato L; Beaure d'Augères G; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Marques R; Nabbout R; O'Callaghan F; Qin J; Sander V; Sauter M; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Kingswood JC; Jansen AC;
Front Neurol; 2020; 11():603. PubMed ID: 32733359
[No Abstract] [Full Text] [Related]
30. The use of everolimus in the treatment of neurocognitive problems in tuberous sclerosis (TRON): study protocol for a randomised controlled trial.
Randell E; McNamara R; Davies DM; Owen-Jones E; Kirby N; Angel L; Drew C; Cannings-John R; Smalley M; Saxena A; McDermott E; Stockwell L; de Vries PJ; Hood K; Sampson JR
Trials; 2016 Aug; 17():398. PubMed ID: 27515417
[TBL] [Abstract][Full Text] [Related]
31. Assessment of tuberous sclerosis-associated neuropsychiatric disorders using the MINI-KID tool: a pediatric case-control study.
Ding Y; Wang J; Zhou H; Li T; Zhou S; Wang Y
Orphanet J Rare Dis; 2021 Apr; 16(1):181. PubMed ID: 33865427
[TBL] [Abstract][Full Text] [Related]
32. New insights into the pathogenesis and prevention of tuberous sclerosis-associated neuropsychiatric disorders (TAND).
Gipson TT; Johnston MV
F1000Res; 2017; 6():. PubMed ID: 28663780
[TBL] [Abstract][Full Text] [Related]
33. Tuberous sclerosis: a review of the past, present, and future.
Uysal SP; Şahin M
Turk J Med Sci; 2020 Nov; 50(SI-2):1665-1676. PubMed ID: 32222129
[TBL]